Pharmacoepidemiology and drug safety · 2024
Handling With Vaccine Type Missing Data in a Dynamic Cohort to Assess the Link Between Time-Varying Vaccination and an Autoimmune Disease.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Castillo-Cano Belén, Comas-Cufí Marc, Martín-Merino Elisa
Аннотация
OBJECTIVE: The information about the type of vaccine administrated may be missing in patients' health records. We aimed to apply a simple strategy, based on several factors, to impute, when missing, the type of administrated human papillomavirus (HPV) vaccines to study its association with thyroiditis.
METHODS: The cohort study included Spanish health records (BIFAP) of girls. Follow-up time was divided into non-exposed, exposed, and post-exposed. The vaccine type was obtained through a single stochastic imputation based on (non)clinical factors associated with both, missing and recorded values of 1st dose, confounders and outcome. HRs were estimated after imputation. As a secondary analysis, these were compared to other strategies: using only girls with vaccine type recorded (complete cases; CC) and all girls, including those without type recorded in a missing category (MiCat).
RESULTS: A total of 808 201 observations for 388 411 girls were built. Vaccination type was carried out in 2.84% of 153 924 vaccinated girls remaining 35% for imputation. Fifteen factors associated and four confounders were identified for the imputation. HR departed by up to 10% overestimation for bi- and 10% underestimation for quadri- valent in the MiCat, whilst 24% and 3% respectively in the CC.
CONCLUSIONS: In our example, multiple factors associated with HPV vaccine type missing and values were identified suggesting missing not completely at random. Thus, CC and MiCat could bias the estimates. Those factors were used for imputation, doing more plausible the missing at random assumption. This strategy was simple, efficient and can be easily applied to analyses time-varying exposure in pharmacoepidemiology.
METHODS: The cohort study included Spanish health records (BIFAP) of girls. Follow-up time was divided into non-exposed, exposed, and post-exposed. The vaccine type was obtained through a single stochastic imputation based on (non)clinical factors associated with both, missing and recorded values of 1st dose, confounders and outcome. HRs were estimated after imputation. As a secondary analysis, these were compared to other strategies: using only girls with vaccine type recorded (complete cases; CC) and all girls, including those without type recorded in a missing category (MiCat).
RESULTS: A total of 808 201 observations for 388 411 girls were built. Vaccination type was carried out in 2.84% of 153 924 vaccinated girls remaining 35% for imputation. Fifteen factors associated and four confounders were identified for the imputation. HR departed by up to 10% overestimation for bi- and 10% underestimation for quadri- valent in the MiCat, whilst 24% and 3% respectively in the CC.
CONCLUSIONS: In our example, multiple factors associated with HPV vaccine type missing and values were identified suggesting missing not completely at random. Thus, CC and MiCat could bias the estimates. Those factors were used for imputation, doing more plausible the missing at random assumption. This strategy was simple, efficient and can be easily applied to analyses time-varying exposure in pharmacoepidemiology.